Treatment of Langerhans Cell Histiocytosis With a Modified Risk-Adapted Protocol-Experience From a Tertiary Cancer Institute in India
Pediatric Blood and Cancer - United States
doi 10.1002/pbc.27028
Full Text
Open PDFAbstract
Available in full text
Date
March 7, 2018
Authors
Publisher
Wiley